Jones Trading Reiterates Buy Rating on iBio, Inc. (IBIO) amid pipeline expansion

March 18, 2026 4:47 PM

Jones Trading analyst Catherine Novack reiterated a Buy rating and $7.00 price target on iBio, Inc. (NASDAQ: IBIO)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found